AU2003299821B2 - Antibiotics containing borinic acid complexes and methods of use - Google Patents

Antibiotics containing borinic acid complexes and methods of use Download PDF

Info

Publication number
AU2003299821B2
AU2003299821B2 AU2003299821A AU2003299821A AU2003299821B2 AU 2003299821 B2 AU2003299821 B2 AU 2003299821B2 AU 2003299821 A AU2003299821 A AU 2003299821A AU 2003299821 A AU2003299821 A AU 2003299821A AU 2003299821 B2 AU2003299821 B2 AU 2003299821B2
Authority
AU
Australia
Prior art keywords
alkyl
substituted
compound
species
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003299821A
Other languages
English (en)
Other versions
AU2003299821A1 (en
Inventor
Stephen J. Benkovic
Ving Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anacor Pharmaceuticals LLC
Original Assignee
Anacor Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals LLC filed Critical Anacor Pharmaceuticals LLC
Publication of AU2003299821A1 publication Critical patent/AU2003299821A1/en
Application granted granted Critical
Publication of AU2003299821B2 publication Critical patent/AU2003299821B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003299821A 2002-12-18 2003-12-18 Antibiotics containing borinic acid complexes and methods of use Ceased AU2003299821B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US43437502P 2002-12-18 2002-12-18
US60/434,375 2002-12-18
US43609502P 2002-12-23 2002-12-23
US60/436,095 2002-12-23
US43784903P 2003-01-03 2003-01-03
US60/437,849 2003-01-03
PCT/US2003/040982 WO2004056322A2 (en) 2002-12-18 2003-12-18 Antibiotics containing borinic acid complexes and methods of use

Publications (2)

Publication Number Publication Date
AU2003299821A1 AU2003299821A1 (en) 2004-07-14
AU2003299821B2 true AU2003299821B2 (en) 2010-02-18

Family

ID=32686073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003299821A Ceased AU2003299821B2 (en) 2002-12-18 2003-12-18 Antibiotics containing borinic acid complexes and methods of use

Country Status (11)

Country Link
US (2) US20040224923A1 (enExample)
EP (2) EP1581500A4 (enExample)
JP (2) JP2006511613A (enExample)
KR (1) KR20050084378A (enExample)
CN (1) CN101928295A (enExample)
AU (1) AU2003299821B2 (enExample)
BR (1) BR0317564A (enExample)
CA (1) CA2509645A1 (enExample)
MX (1) MXPA05006685A (enExample)
NZ (1) NZ540870A (enExample)
WO (1) WO2004056322A2 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1325504C (zh) 2002-01-10 2007-07-11 宾夕法尼亚州研究基金会 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
MXPA05006685A (es) * 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.
AR049916A1 (es) * 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Usos anti-parasitarios de complejos de acido borinico
AR049915A1 (es) * 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
EP1765360B1 (en) 2004-06-14 2009-11-11 Anacor Pharmaceuticals, Inc. Anti-viral uses of borinic acid complexes
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
ES2872962T3 (es) 2005-02-16 2021-11-03 Anacor Pharmaceuticals Inc Boronoftalidas para uso terapéutico
MX2007011486A (es) * 2005-03-24 2007-11-20 Anacor Pharmaceuticals Inc Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.
EP1965647A2 (en) * 2005-12-28 2008-09-10 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
RU2642628C2 (ru) 2006-02-16 2018-01-25 Анакор Фармасьютикалз, Инк. Бор-содержащие малые молекулы в качестве противовоспалительных средств
US20070286822A1 (en) * 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
BRPI0713010A2 (pt) * 2006-06-12 2012-10-09 Anacor Pharmaceuticals Inc compostos para o tratamento de doença periodontal
EP2069370A4 (en) * 2006-11-22 2011-05-04 Anacor Pharmaceuticals Inc MICRO-ORGANISMS KILLING COMPOUNDS
EP3246034A1 (en) 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
US20100256092A1 (en) * 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010027975A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
SG172040A1 (en) * 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
EP2458995A1 (en) 2009-07-28 2012-06-06 Anacor Pharmaceuticals, Inc. Trisubstituted boron-containing molecules
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
US20110207701A1 (en) * 2009-08-19 2011-08-25 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) * 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US8461134B2 (en) * 2009-11-11 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011116348A1 (en) 2010-03-19 2011-09-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agent
DK2613788T3 (en) 2010-09-07 2017-08-07 Anacor Pharmaceuticals Inc BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
AR094666A1 (es) 2013-01-30 2015-08-19 Dow Agrosciences Llc Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
BR112016003692B1 (pt) * 2013-08-20 2022-02-08 3M Innovative Properties Company Complexo poliéter boro-silano
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
IL248150B (en) 2016-09-29 2018-05-31 Garti Nissim Method for selective extraction of cannabinoids from a plant source
IL248149B (en) 2016-09-29 2020-03-31 Garti Nissim Dilutable formulations of cannbinoids and processes for their preparation
EP3522892A4 (en) * 2016-10-05 2020-05-13 The Global Alliance for TB Drug Development, Inc. HETEROARYL TRIFLUORBORATE COMPOUNDS FOR TREATING MYCOBACTERIAL INFECTIONS
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
CA3054138A1 (en) * 2017-03-09 2018-09-13 The Penn State Research Foundation Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase
EP3840637B1 (en) * 2018-08-20 2025-08-06 Senseonics, Incorporated Mediated drug release for reducing in vivo analyte indicator degradation
WO2022043936A1 (en) 2020-08-31 2022-03-03 Pfizer Inc. Methods of protecting rna
US12357552B2 (en) 2021-03-09 2025-07-15 Juris GERMANAS Hydroxyquinoline compounds and methods of use as pigment modifying agents

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5348948A (en) * 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
EP0969531A2 (de) * 1998-07-04 2000-01-05 Bayer Aktiengesellschaft Elektrolumineszierende Anordungen mit Bor-Chelaten
WO2000075142A2 (en) * 1999-05-25 2000-12-14 The Penn State Research Foundation Dna methyltransferase inhibitors
EP1155698A1 (en) * 1999-01-29 2001-11-21 Nitto Kasei Co., Ltd. Organoboron compounds exhibiting anticoccidial activities
WO2003059916A2 (en) * 2002-01-10 2003-07-24 The Pennsylvania State Research Foundation Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0496757B1 (de) * 1989-10-18 1995-07-12 Hoechst Schering AgrEvo GmbH Verfahren zur bekämpfung von schadpflanzen in reis
JPH0952893A (ja) * 1995-08-10 1997-02-25 Yoshitomi Pharmaceut Ind Ltd キノロンカルボン酸誘導体の工業的な製造法およびその合成中間体
DE10110051C2 (de) * 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
JP2002322007A (ja) * 2001-04-27 2002-11-08 Shionogi & Co Ltd 有機ホウ素化合物を含有する植物用殺線虫剤
MXPA05006685A (es) * 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5348948A (en) * 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
EP0969531A2 (de) * 1998-07-04 2000-01-05 Bayer Aktiengesellschaft Elektrolumineszierende Anordungen mit Bor-Chelaten
EP1155698A1 (en) * 1999-01-29 2001-11-21 Nitto Kasei Co., Ltd. Organoboron compounds exhibiting anticoccidial activities
WO2000075142A2 (en) * 1999-05-25 2000-12-14 The Penn State Research Foundation Dna methyltransferase inhibitors
WO2003059916A2 (en) * 2002-01-10 2003-07-24 The Pennsylvania State Research Foundation Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Bailey et al. Antimicrobial Agents and Chemotherapy 1980, 17(4), 549-553 *
Brown et al. J. Org. Chem 1986, 51(24), 4526-4530 *
Lin et al. Yiyao Gongye 1985, 16(11), 500-502 *
Nefkens et al. Tetrahedron 1985, 41(24), 6063-6066 *
Shan et al. Gaodeng Xuexiao Huaxue Xuebao 1989, 10(9), 965-967 *
Shan et al. Wuhan Daxue Xuebao, Ziran Kexueban 1990, (3), 67-72 *
Toporcer et al. Inorganic Chemistry 1965, 4(11), 1649-1655 *

Also Published As

Publication number Publication date
US20040224923A1 (en) 2004-11-11
EP1980564A1 (en) 2008-10-15
AU2003299821A1 (en) 2004-07-14
NZ540870A (en) 2008-09-26
EP1581500A2 (en) 2005-10-05
CA2509645A1 (en) 2004-07-08
EP1581500A4 (en) 2008-03-05
MXPA05006685A (es) 2005-12-14
KR20050084378A (ko) 2005-08-26
WO2004056322A3 (en) 2004-09-16
WO2004056322A2 (en) 2004-07-08
CN101928295A (zh) 2010-12-29
US20080146803A1 (en) 2008-06-19
JP2009161540A (ja) 2009-07-23
JP2006511613A (ja) 2006-04-06
BR0317564A (pt) 2005-11-22

Similar Documents

Publication Publication Date Title
US7888356B2 (en) Antibiotics containing borinic acid complexes and methods of use
US20040224923A1 (en) Antibiotics containing borinic acid complexes and methods of use
US7968752B2 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
AU2003205089B2 (en) Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids
US7652000B2 (en) Boron-containing compounds and methods of use
RU2397986C2 (ru) Антибиотики, содержащие комплексы бориновой кислоты, и способы их получения
HK1117168A (en) Antibiotics containing borinic acid complexes and methods of use
ZA200504939B (en) Antibiotics containing borinic acid complexes and methods of use
JP4520461B2 (ja) 加水分解抵抗性ホウ素含有治療薬および使用法
JP2010070557A (ja) 加水分解抵抗性ホウ素含有治療薬および使用法
HK1085216A (en) Antibiotics containing borinic acid complexes and methods of use

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired